Randomized trial of contrast media utilization in high-risk PTCA: The COURT trial

Circulation

Volumn 101, Issue 18, 2000, Pages 2172-2177

  Davidson, Charles J ^a,m   Laskey, Warren K ^b   Hermiller, James B ^c   Harrison, J Kevin ^d   Matthai Jr , William ^e   Vlietstra, Ronald E ^f   Brinker, Jeffrey A ^g   Kereiakes, Dean J ^h   Muhlestein, Joseph B ⁱ   Lansky, Alexandra ^j   Popma, Jeffrey J ^j   Buchbinder, Maurice ^k   Hirshfeld Jr , John W ^l  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c Care Group   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e PENN PRESBYTERIAN MEDICAL CENTER   (United States)

^f LAKELAND REGIONAL MEDICAL CENTER   (United States)

^g JOHNS HOPKINS HOSPITAL   (United States)

^h The Carl & Edyth Lindner Center for Research & Education   (United States)

ⁱ Latter Day Saints Hospital   (United States)

^j WASHINGTON HOSPITAL CENTER   (United States)

^k SCRIPPS MEMORIAL HOSPITAL   (United States)

^l HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^m NORTHWESTERN UNIVERSITY   (United States)

more..

Author keywords

Angioplasty; Contrast media; Myocardial infarction

Indexed keywords

ABCIXIMAB; IODIXANOL; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; VISIPAQUE 320;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CINEANGIOCARDIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION; STROKE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0034625176     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.18.2172     Document Type: Article

References (25)

1. EPILOG-investigators. GP IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med. 1997;336:1689-1696.
2. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Clemen M, Heuser R, Almond D, Teirstein PS, Fish D, Colombo A, Brinker J, Moses J, Shanknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S, for the Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement an balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.
3. Serruys PW, de Jaegere P, Kiemeneij F, Magaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, Van Den Heuvel P, Delcan J, Morel MA, for the Benestent Study Group. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495.
4. The EPIC Investigators. Use of a monoclonal antibody directed against the glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 1994;330:956-961.
5. Grines CL, Schrieber TL, Savas V, Jones DE, Zidar FJ, Gangadharam V, Brodsky M, Levin R, Safian R, Puchrowicz-Ochocki S, Castellani MD, O'Neill WW. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1996;27:1381-1386.
6. Gasperetti CM, Feldman MD, Burwell LR, Angello DA, Haugh KH, Owen RM, Powers ER. Influence of contrast media on thrombus formation during coronary angioplasty. J Am Coll Cardiol. 1991;18:443-450.
7. Chronos NAF, Goodall AH, Wilson DJ, Sigwart U, Buller NP. Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology. Circulation. 1993;88(pt 1):2035-2044.
8. Davidson CJ. Contrast media: is there a preferable agent for coronary interventions? J Am Coll Cardiol. 1997;29:1122-1123.
9. Bettman MA, Higgins CB. Comparison of an ionic with a nonionic contrast agent for cardiac angiography results of a multicenter trial. Invest Radiol. 1985;20:570-574.
10. Bashore TM, Davidson CJ, Mark DB, Kisslo K, Hlatky M, Skelton TN. Lopamidol use in the cardiac catheterization laboratory: a retrospective analysis of 3312 patients. Cardiology. 1985;5:4-10.
11. Ciuffo AA, Fuchs RM, Guzman PA, Brin KP, Kross DE, Weiss JL, Feroli RW, Brinker JA. Benefits of nonionic contrast in coronary arteriography: preliminary results of a randomized double-blind trial comparing iopamidol with Renografin-76. Invest Radiol. 1984;19:5197-8202.
12. Stormorken H, Skalpe IO, Testart MC. Effect of various contrast media on coagulation, fibrinolysis, and platelet function: an in vitro study. Invest Radiol. 1986;21:348-354.
13. Belleville J, Baquet J, Paul J, Clendinnen G, Elroy R. In vitro study of the inhibition of coagulation induced by different radioconstrast molecules. Thromb Res. 1985;38:149-162.
14. Davidson CJ, Mark DB, Pieper KS, Kisslo KB, Hlatky MA, Gabriel DA, Bashore TM. Thrombotic and cardiovascular complications related to non-ionic contrast media during cardiac catheterization; analysis of 8,517 patients. Am J Cardiol. 1990;65:1481-1484.
15. Piessens JH, Stammen F, Vrolix MC, Glazier JJ, Benit E, De Geest J, Willems JL. Effects of an ionic versus a nonionic low osmolar contrast agent on the thrombotic complications of coronary angioplasty. Cathet Cardiovasc Diagn. 1993;28:99-105.
16. Hill JA, Cohen MB, Kou WH, Mancini J, Mansour M, Fountaine Harvey, Brinker JA. Iodixanol, a new isosmotic nonionic contrast agent compared with iohexol in cardiac angiography. Am J Cardiol. 1994;74:57-63.
17. Grabowski EF, Jang IV, Gold H, Head C, Benoit SE, Michelson AD. Variability of platelet degranulation by different contrast media. Acad Radiol. 1996;3:S485-S487.
18. Grabowski EF, Head C, Michelson AD. Nonionic contrast media: procoagulants or clotting innocents? Invest Radiol 1993;28:S21-S24.
19. Lansky AJ, Popma JJ. Qualitative and quantitative angiography. In: Topol E, ed. Textbook of Interventional Cardiology. 3rd ed. Philidelphia. Pa: WB Saunders; 1999:725-747.
20. Robertson HJF. Blood clot formation and angiographic syringes containing non-ionic contrast media. Radiology. 1987;163:621-622.
21. Gabriel DA, Jones MR, Reece NS, Boothroyd E, Bashore T. Platelet and fibrin modification by radiographic contrast media. Circ Res. 1991;68: 881-887.
22. Schräder R, Esch I, Ensslen R, Fach WA, Merle H, Scherer D, Sievert H, Spies HF, Zeplin HE. A randomized trial comparing the impact of nonionic (iomeprol) versus an ionic (ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after angioplasty. J Am Coll Cardiol. 1999;33:395-402.
23. Bertrand ME, Esplugas E, Piessens J, et al. Influence of a nonionic, iso-osmolar contrast medium (iodixonal) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: a multicenter, randomized, double-blind study. Circulation. 2000;101:131-136.
24. Owens MR, Ribes JA, Marder VJ, Francis CW. Effects of ionic and nonionic radiographic contrast agents on endothelial cells in vitro. J Lab Clin Med. 1992;119:315-319.
25. Riemann CD, Massey CV, McCarron DL, Borkowski P, Johnson PC, Ziskind AA. Ionic contrast agent-mediated endothelial injury causes increased platelet deposition to vascular surfaces. Am Heart J. 1993;125: 71-78.